Bcl-2 was downregulated in G2/M-arrest breast cancer cells MCF-7-treated with nordamnacanthal by Saiful Yazan, Latifah et al.




Nordamnacanthal, an anthraquinone extracted from the root of Morinda elliptica has 
cytotoxic properties towards various cancer cell lines and antitumor-promoting activities. 
This study was conducted to determine the effects of nordamnacanthal on the cell cycle, and 
the expression of Bcl-2 and Bax in breast cancer (MCF-7) and acute t-lymphoblastic 
leukemia (MOLT-4) cells at 50% of the total cell population underwent apoptosis. 
Nordamnacanthal caused 50% of MCF-7 and MOLT-4 cells underwent apoptosis at 15 μg/ml 
and 70 μg/ml, respectively, as analyzed by using a fluorescence microscope following 
staining with the acridine orange (AO) and propidium iodide (PI). The apoptotic cells 
exhibited nuclear fragmentation, chromatin condensation in the nucleus and membrane 
blebbing. Cell cycle analysis by flow cytometry indicated that nordamnacanthal arrested 
MCF-7 cells at the G2/M phase. For MOLT-4, no cell cycle arrest was observed. Bcl-2 and 
Bax were downregulated in nordamnacanthal-treated MCF-7 cells. On the other hand, 
expression of the proteins in MOLT-4 was not significantly different (p>0.05) from the 
control. In conclusion, treatment of MCF-7 cells with nordamnacanthal at the concentration 
that caused 50% of the total cell population underwent apoptosis, induced the G2/M arrest 
with downregulation of Bcl-2. 
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